We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

45 hedge funds and large institutions have $5.19M invested in Nymox Pharmaceutical Corp in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

36% more capital invested

Capital invested by funds: $3.8M → $5.19M (+$1.39M)

18% more funds holding

Funds holding: 38 → 45 (+7)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

33% less call options, than puts

Call options by funds: $27K | Put options by funds: $40K

Holders
45
Holders Change
+7
Holders Change %
+18.42%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
9
Reduced
11
Closed
3
Calls
$27K
Puts
$40K
Net Calls
-$13K
Net Calls Change
-$21K

Top Buyers

Rank Fund Capital Flow
1
ECM
ExodusPoint Capital Management
New York
+$194K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$178K
3
6CM
683 Capital Management
New York
+$169K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$132K
5
PFGIA
Patriot Financial Group Insurance Agency
Massachusetts
+$71K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$219K
2
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$98.7K
3
LP
LMR Partners
United Kingdom
-$64K
4
WS
Wedbush Securities
California
-$39.9K
5
Bank of America
Bank of America
North Carolina
-$38.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
26
California Public Employees Retirement System
California
$44K – – –
JP Morgan Chase
27
JP Morgan Chase
New York
$42K -$1.79K -907 -5%
Credit Agricole
28
Credit Agricole
France
$40K – – –
AGM
29
Alpine Global Management
New York
$38K +$33.9K +17,196 New
Deutsche Bank
30
Deutsche Bank
Germany
$30K +$11.9K +6,039 +77%
HighTower Advisors
31
HighTower Advisors
Illinois
$27K -$3.95K -2,000 -14%
TRCT
32
Tower Research Capital (TRC)
New York
$25K +$18.8K +9,535 +482%
LNC
33
Lincoln National Corp
Pennsylvania
$22K +$19.7K +10,000 New
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$15K -$9.87K -5,000 -42%
LTFS
35
Ladenburg Thalmann Financial Services
Florida
$11K +$987 +500 +11%
LIA
36
LS Investment Advisors
Michigan
$7K – – –
UBS Group
37
UBS Group
Switzerland
$5K -$1.92K -972 -31%
SIAP
38
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$5K – – –
Group One Trading
39
Group One Trading
Illinois
$3K +$2.76K +1,400 +1,818%
PP
40
Pacifica Partners
Canada
$3K +$2.77K +1,406 New
ClearBridge Investments
41
ClearBridge Investments
New York
$2K – – –
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$1K – – –
SPIA
43
Steward Partners Investment Advisory
New York
$1K – – –
VRM
44
Vectors Research Management
New York
$1K – – –
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$407 -$6.85K -3,470 -95%
LP
46
LMR Partners
United Kingdom
– -$64K -34,819 Closed
WP
47
WMS Partners
Maryland
– -$33K -18,000 Closed
Citigroup
48
Citigroup
New York
– -$7K -3,652 Closed
1
2

NYMX Hedge Fund Activity: Q4 2019 in Review

45 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q4 2019, worth a combined $5.19M — up 36% from $3.8M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new NYMX positions and 3 closed out — a net gain of 7 holders — while 9 added to existing stakes and 11 trimmed.

The largest buyer was ExodusPoint Capital Management, opening a new position worth an estimated $194K. The largest seller was Millennium Management, cutting an estimated $219K.

  • 45 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q4 2019, up from 38 in Q3 2019.
  • Funds reported $5.19M of Nymox Pharmaceutical Corp stock for Q4 2019, up 36% quarter-over-quarter.
  • 10 funds opened new Nymox Pharmaceutical Corp positions in Q4 2019 and 3 closed out, a net change of +7 holders.
  • The largest Nymox Pharmaceutical Corp buyer in Q4 2019 was ExodusPoint Capital Management, an estimated $194K added.
  • The largest Nymox Pharmaceutical Corp seller in Q4 2019 was Millennium Management, an estimated $219K sold.

Based on aggregated 13F filings for Q4 2019.